Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial
Primary result · TIRResult — go to the resultLS mean difference 10.0 % 95% CI 2.1–18.0Authors' conclusion
In this RCT, real-time CGM and telemonitoring improved glycaemic control during postoperative period without increasing hypoglycaemia risk. Given the benefits of effective glycaemic control on perioperative outcomes, CGM may be helpful in managing T2D after CABG.
Study context
- Population
- Adults with T2D undergoing coronary artery bypass grafting (CABG)
- Participants
- 91 adults
- Comparison
- Real-time continuous glucose monitoring (CGM) and telemetry vs blinded CGM with point-of-care measures
- Testn = 48
- Controln = 43reference
- Primary endpoint
- Percentage TIR of blood glucose 70–180 mg/dL (3.9-10.0 mmol/L), measured by CGM
- Follow-up
- Postoperative period
Primary result
TIR
Least squares (LS) mean difference
10.0 %
95% CI 2.1–18.0
P = 0.014
By group
Testvs Control
LS mean difference 10.0 % (95% CI 2.1–18.0); P = 0.014
As reported in the abstract
Further findings
TAR and mean glucose
- Test had lower TAR and mean glucose levels
TBR
- No differences in TBR
Safety
- No differences in hypoglycaemic events
Original publication
Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial. Diabetes Obes Metab. Published 7 January 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →